In a cohort study on urothelial bladder cancers, the expression of STAB1 on TAMs but not lymphatic endothelial cells correlated with poor response to neoadjuvant chemotherapy and reduced overall survival [48]. The gene discussed is STAB1; the disease is bladder transitional cell carcinoma.